Company news

Insulet Corporation news in 2024

Insulet Corporation's news releases, calls and decks from 2024, newest first.

View company

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

December 3, 2024

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.

November 19, 2024

Insulet to Present at Upcoming Investor Conferences

November 14, 2024

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹)

November 6, 2024

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

October 31, 2024

Omnipod® 5 App for iPhone® Now Fully Available in the United States

October 28, 2024

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

September 29, 2024

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

August 25, 2024

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

August 13, 2024

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

August 7, 2024

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

July 25, 2024

Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors

July 24, 2024

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

July 7, 2024

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

June 20, 2024

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

June 19, 2024

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

June 19, 2024

Insulet to Present at the Jefferies Global Healthcare Conference

May 27, 2024

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

May 8, 2024

Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

May 6, 2024

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

April 2, 2024

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

March 19, 2024

Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

March 7, 2024

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 4, 2024

Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency¹) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)

February 21, 2024

Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference

February 12, 2024

Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor

February 6, 2024

Imperative Care Announces Four Senior Leadership Appointments

January 28, 2024

Insulet Announces Changes to Board of Directors with Retirements and New Appointments

January 17, 2024

Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

January 10, 2024

Calls in 2024

Decks in 2024